Back to Search
Start Over
Aerosolized drug delivery in awake and anesthetized children to treat bronchospasm
- Source :
- Pediatric Anesthesia. 32:156-166
- Publication Year :
- 2021
- Publisher :
- Wiley, 2021.
-
Abstract
- Bronchospasm is a common respiratory adverse event in pediatric anesthesia. First line treatment commonly includes inhaled salbutamol. This review focusses on the current best practice to deliver aerosolized medications to awake as well as anesthetized pediatric patients and discusses the advantages and disadvantages of various administration techniques. Additionally, we detail the differences between various airway devices used in anesthesia. We highlight the unmet need for innovation of orally inhaled drug-products to deliver aerosolized medications during pediatric respiratory critical events such as bronchospasm. It is therefore important that clinicians remain up to date with the best clinical practice for aerosolized drug delivery in order to prevent and efficiently treat pediatric patients experiencing life-threatening respiratory emergencies.
- Subjects :
- medicine.medical_specialty
Bronchospasm
Administration, Inhalation
Humans
Medicine
Albuterol
Wakefulness
Child
Intensive care medicine
Adverse effect
Aerosolization
Aerosols
Bronchial Spasm
business.industry
Nebulizers and Vaporizers
respiratory system
First line treatment
Nebulizer
Anesthesiology and Pain Medicine
Pediatrics, Perinatology and Child Health
Drug delivery
Salbutamol
medicine.symptom
business
Pediatric anesthesia
medicine.drug
Subjects
Details
- ISSN :
- 14609592 and 11555645
- Volume :
- 32
- Database :
- OpenAIRE
- Journal :
- Pediatric Anesthesia
- Accession number :
- edsair.doi.dedup.....7617b0ef9766d5b359e7f8d282164a0a